Department of Pharmaceutical Sciences, University of Colorado Denver, 12700 E 19th Avenue, C238-P15, Aurora, CO 80045, USA.
Nanomedicine (Lond). 2010 Apr;5(3):485-505. doi: 10.2217/nnm.10.10.
Micellar delivery systems smaller than 100 nm can be readily prepared. While micelles allow a great depth of tissue penetration for targeted drug delivery, they usually disintegrate rapidly in the body. Thus, sustained drug delivery from micellar nanocarriers is a challenge. This article summarizes various key strategies and underlying principles for sustained drug delivery using micellar nanocarriers. Comparisons are made with other competing delivery systems such as polymeric microparticles and nanoparticles. Amphiphilic molecules self-assemble in appropriate liquid media to form nanoscale micelles. Strategies for sustained release nanomicellar carriers include use of prodrugs, drug polymer conjugates, novel polymers with low critical micellar concentration or of a reverse thermoresponsive nature, reverse micelles, multi-layer micelles with layer by layer assembly, polymeric films capable of forming micelles in vivo and micelle coats on a solid support. These new micellar systems are promising for sustained drug delivery.
胶束递送系统可以很容易地制备成小于 100nm 的尺寸。虽然胶束允许药物靶向递送到更深的组织中,但它们通常在体内迅速分解。因此,从胶束纳米载体中持续释放药物是一个挑战。本文总结了使用胶束纳米载体进行持续药物递送的各种关键策略和基本原理。并与其他竞争的递药系统(如聚合物微球和纳米粒)进行了比较。两亲性分子在适当的液体介质中自组装形成纳米级胶束。用于持续释放纳米胶束载体的策略包括使用前药、药物聚合物偶联物、具有低临界胶束浓度或反向热敏性质的新型聚合物、反胶束、具有层层组装的多层胶束、能够在体内形成胶束的聚合物膜以及固体载体上的胶束涂层。这些新的胶束系统有望用于持续药物递送。